Angioimmunoblastic lymphadenopathy-like T-cell lymphoma: cutaneous clinical onset with prominent granulomatous reaction.
D. Suárez‐Vilela,F. Izquierdo-García
DOI: https://doi.org/10.1097/00000478-200305000-00015
2003-05-01
Abstract:To the Editor: We have read the interesting article of Scarabello et al. about cutaneous lymphomas with prominent granulomatous reaction. One of the cases corresponded to a secondary infiltration by a peripheral T-cell lymphoma, not otherwise specified, initially diagnosed as granulomatous lymphadenitis. We have studied a similar case in a patient with cutaneous lesions, first diagnosed as sarcoidosis, but later, on the review of the case, it was confirmed that it was in reality an angioimmunoblastic lymphadenopathy-like T-cell lymphoma (AILD-like) with a prominent granulomatous reaction. Our case is that of a 67-year-old woman with nodular cutaneous lesions on the trunk since 2 years before, who was sent to the Department of Dermatology of our hospital in May 2000, with the diagnosis of sarcoidosis in another center. She had a partial response with several topic therapies, including corticoids. A new biopsy showed nodular granulomatous infiltrate in middle and profound dermis and fatty subcutaneous tissue. The granulomas were perivascular and periadnexal, and they were made up of epithelioid histiocytes, Langhans-type giant cells, and lymphocytes of different sizes, including some scattered blastic cells (Fig. 1A, B). Some granulomas showed vascular proliferation with high endothelium venules. With the stains of Ziehl-Neelsen, Fite Faraco, and periodic acid–Schiff, both with and without diastase digestion, acid-alcohol bacteria and fungus were not found. In the immunohistochemical study, most of the lymphocytes stained with antibodies against T-cell antigens: CD3 (Novocastra, Newcastle, England), CD5 (Novocastra), CD43 (Biogenex, San Ramón, CA, USA), CD4 (90%, Novocastra), and CD8 (10%, Dako, Carpinteria, CA, USA). The blastic cells showed a B-cell phenotype, being positive for CD20 (Dako), CD79A (Dako), and CDw75 (Biogenex). The histiocytes and giant cells were stained for CD68 (Dako). With the in situ hybridization (ISH) method, for Epstein Barr virus, numerous blastic cells were positive. The molecular study made with the polymerase chain reaction method, both a-cell receptorand IgH chain rearrangements were demonstrated. In June 2000, the patient developed lymphadenopathies on the right parotid region. On the biopsy, an AILD-like lymphoma with an intense granulomatous reaction was found. Both immunohistochemical and in situ hybridization findings were similar to the previous cutaneous biopsy, but on polymerase chain reaction only T-cell receptorrearrangement was found, though not the IgH chain rearrangement. The patient was treated with chemotherapy, and currently she has bilateral residual disease in both axillar lymph nodes and lungs. A small to moderate number of epithelioid histiocytes and Langhans’ giant cells have been described as AILDlike. This type of lymphoma may also have a clinical onset with a cutaneous involvement with several histologic patterns. Nevertheless, a prominent granulomatous reaction as in our case is not usual, and it may result in important diagnostic pitfalls as initially in our case. Our findings are similar to those of Scarabello et al., and they show the diagnostic difficulties of the primary or secondary cutaneous lymphomas with prominent granulomatous reaction. Like Scarabello et al., we think that before cutaneous granulomas with atypical lymphocytes a lymphoproliferative neoplasm must be ruled out. Both immunohistochemical and molecular studies may resolve this problem.